首页> 美国卫生研究院文献>Molecular Medicine Reports >Transcription factor glioma-associated oncogene homolog 1 is required for transforming growth factor-β1-induced epithelial-mesenchymal transition of non-small cell lung cancer cells
【2h】

Transcription factor glioma-associated oncogene homolog 1 is required for transforming growth factor-β1-induced epithelial-mesenchymal transition of non-small cell lung cancer cells

机译:转录因子胶质瘤相关癌基因同源物1是转化生长因子-β1诱导的非小细胞肺癌细胞上皮-间质转化的必需条件

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Epithelial-mesenchymal transition (EMT) is the process by which epithelial cells depolarize and acquire a mesenchymal phenotype, and is a common early step in the process of metastasis. Patients with lung cancer frequently already have distant metastases when they are diagnosed, highlighting the requirement for early and effective interventions to control metastatic disease. Transforming growth factor-β1 (TGF-β1) is able to induce EMT, however the molecular mechanism of this remains unclear. In the current study, TGF-β1 was reported to induce EMT and promote the migration of non-small cell lung cancer (NSCLC) cells. A notable observation was that EMT induction was accompanied by the upregulation of human glioma-associated oncogene homolog 1 (Gli1) mRNA and protein levels. Furthermore, Gli1 levels were depleted by small interfering RNA, and the Gli1 inhibitor GANT 61 attenuated the TGF-β1-mediated induction of EMT and cell migration. The results of the current study suggest that Gli1 regulates TGF-β1-induced EMT, which may provide a novel therapeutic target to inhibit metastasis in patients with NSCLC.
机译:上皮-间质转化(EMT)是上皮细胞去极化并获得间质表型的过程,是转移过程中的常见早期步骤。肺癌患者在被诊断出时往往已经有远处转移,这凸显了对早期有效干预以控制转移性疾病的需求。转化生长因子-β1(TGF-β1)能够诱导EMT,但是其分子机制仍不清楚。在当前的研究中,据报道TGF-β1诱导EMT并促进非小细胞肺癌(NSCLC)细胞的迁移。值得注意的观察是,EMT诱导伴随着人类神经胶质瘤相关癌基因同源物1(Gli1)mRNA和蛋白质水平的上调。此外,小干扰RNA耗尽了Gli1水平,而Gli1抑制剂GANT 61减弱了TGF-β1介导的EMT诱导和细胞迁移。目前的研究结果表明,Gli1调节TGF-β1诱导的EMT,这可能为抑制NSCLC患者的转移提供了新的治疗靶点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号